Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global and United States Recombinant Human CNTF Market Report & Forecast 2024-2030
Global and United States Recombinant Human CNTF Market Report & Forecast 2024-2030
Industry: Medical Devices & Consumables
Published Date: 2024-11-12
Pages: 127 Pages
Report ld: 3372347
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Recombinant Human CNTF Market Size(US$)
CAGR 2024-2030
7%
Market Size,2030
USD 317
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 211 million
Market Forecast in 2030(Value)
US$ 317 million
CAGR
7%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Recombinant Human CNTF revenue was US$ 198 million in 2023 and is forecast to a readjusted size of US$ 317 million by 2030 with a CAGR of 7.0% during the review period (2024-2030).
In United States the Recombinant Human CNTF revenue is expected to grow from US$ million in 2023 to US$ million by 2030, at a CAGR of % during the forecast period (2024-2030).
This report focuses on global and United States Recombinant Human CNTF market, also covers the segmentation data of other regions in regional level and county level.
Recombinant Human Ciliary Neurotrophic Factor: Ciliary neurotrophic factor (CNTF) is a polypeptide originally purified from chick embryonic eye tissue and identified as a trophic factor for embryonic chick ciliated parasympathetic neurons in culture. Subsequent studies have shown that CNTF is a survival factor for other neural cell types, including: dorsal root ganglion sensory neurons, sympathetic ganglion neurons, embryonic motor neurons, major pelvic ganglion neurons, and hippocampal neurons.
The global key players of Recombinant Human CNTF include STEMCELL, Merck, YEASEN, BPS Bioscience, R&D Systems, Inc., Thermo Fisher Scientific Inc., Cell Guidance Systems LLC, Abcam Limited, ACROBiosystems, Proteintech Group, Inc, etc. The global five biggest players hold a share of % in 2023.
Recombinant Human CNTF market is segmented in regional and country level, by players, by Type, and by Application. Companies, stakeholders, and other participants in the global Recombinant Human CNTF market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2019-2030.
For United States market, this report focuses on the Recombinant Human CNTF market size by players, by Type, and by Application, for the period 2019-2030. The key players include the global and local players which play important roles in United States.
MARKET SEGMENTATION
By Company
- STEMCELL
- Merck
- YEASEN
- BPS Bioscience
- R&D Systems, Inc.
- Thermo Fisher Scientific Inc.
- Cell Guidance Systems LLC
- Abcam Limited
- ACROBiosystems
- Proteintech Group, Inc
- BioLegend, Inc
- InVitria
- Sinobiological
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Purity < 97%
- Purity ≥ 97%
Segment by Application
- Laboratory
- University
- Others
CHAPTER OUTLINE
Chapter 1: Introduces Recombinant Human CNTF definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by Type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by Application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of Recombinant Human CNTF companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of Recombinant Human CNTF in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6: Americas by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by Type, by Application and by region, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Human CNTF sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: research findings and conclusion
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Recombinant Human CNTF Product Introduction
1.2 Global Recombinant Human CNTF Outlook 2019 VS 2023 VS 2030
1.2.1 Global Recombinant Human CNTF Sales in US$ Million for the Year 2019-2030
1.2.2 Global Recombinant Human CNTF Sales in Volume for the Year 2019-2030
1.3 United States Recombinant Human CNTF Outlook 2019 VS 2023 VS 2030
1.3.1 United States Recombinant Human CNTF Sales in US$ Million for the Year 2019-2030
1.3.2 United States Recombinant Human CNTF Sales in Volume for the Year 2019-2030
1.4 Recombinant Human CNTF Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.4.1 The Market Share of United States Recombinant Human CNTF in Global, 2019 VS 2023 VS 2030
1.4.2 The Growth Rate of Recombinant Human CNTF Market Size, United States VS Global, 2019 VS 2023 VS 2030
1.5 Recombinant Human CNTF Market Dynamics
1.5.1 Recombinant Human CNTF Industry Trends
1.5.2 Recombinant Human CNTF Market Drivers
1.5.3 Recombinant Human CNTF Market Challenges
1.5.4 Recombinant Human CNTF Market Restraints
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Recombinant Human CNTF by Type
2.1 Recombinant Human CNTF Market by Type
2.1.1 Purity < 97%
2.1.2 Purity ≥ 97%
2.2 Global Recombinant Human CNTF Market Size by Type
2.2.1 Global Recombinant Human CNTF Sales in Value, by Type (2019, 2023 & 2030)
2.2.2 Global Recombinant Human CNTF Sales in Volume, by Type (2019, 2023 & 2030)
2.2.3 Global Recombinant Human CNTF Average Selling Price (ASP) by Type (2019, 2023 & 2030)
2.3 United States Recombinant Human CNTF Market Size by Type
2.3.1 United States Recombinant Human CNTF Sales in Value, by Type (2019, 2023 & 2030)
2.3.2 United States Recombinant Human CNTF Sales in Volume, by Type (2019, 2023 & 2030)
2.3.3 United States Recombinant Human CNTF Average Selling Price (ASP) by Type (2019, 2023 & 2030)
3 Recombinant Human CNTF by Application
3.1 Recombinant Human CNTF Market by Application
3.1.1 Laboratory
3.1.2 University
3.1.3 Others
3.2 Global Recombinant Human CNTF Market Size by Application
3.2.1 Global Recombinant Human CNTF Sales in Value, by Application (2019, 2023 & 2030)
3.2.2 Global Recombinant Human CNTF Sales in Volume, by Application (2019, 2023 & 2030)
3.2.3 Global Recombinant Human CNTF Average Selling Price (ASP) by Application (2019, 2023 & 2030)
3.3 United States Recombinant Human CNTF Market Size by Application
3.3.1 United States Recombinant Human CNTF Sales in Value, by Application (2019, 2023 & 2030)
3.3.2 United States Recombinant Human CNTF Sales in Volume, by Application (2019, 2023 & 2030)
3.3.3 United States Recombinant Human CNTF Average Selling Price (ASP) by Application (2019, 2023 & 2030)
4 Global Recombinant Human CNTF Competitor Landscape by Company
4.1 Global Recombinant Human CNTF Market Size by Company
4.1.1 Global Key Manufacturers of Recombinant Human CNTF, Ranked by Revenue (2023)
4.1.2 Global Recombinant Human CNTF Revenue by Manufacturer (2019-2024)
4.1.3 Global Recombinant Human CNTF Sales by Manufacturer (2019-2024)
4.1.4 Global Recombinant Human CNTF Price by Manufacturer (2019-2024)
4.2 Global Recombinant Human CNTF Concentration Ratio (CR)
4.2.1 Recombinant Human CNTF Market Concentration Ratio (CR) (2019-2024)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Recombinant Human CNTF in 2023
4.2.3 Global Recombinant Human CNTF Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Recombinant Human CNTF, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Recombinant Human CNTF, Product Offered and Application
4.5 Global Key Manufacturers of Recombinant Human CNTF, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States Recombinant Human CNTF Market Size by Company
4.7.1 Key Players of Recombinant Human CNTF in United States, Ranked by Revenue (2023)
4.7.2 United States Recombinant Human CNTF Revenue by Players (2019-2024)
4.7.3 United States Recombinant Human CNTF Sales by Players (2019-2024)
5 Global Recombinant Human CNTF Market Size by Region
5.1 Global Recombinant Human CNTF Market Size by Region: 2019 VS 2023 VS 2030
5.2 Global Recombinant Human CNTF Market Size in Volume by Region (2019-2030)
5.2.1 Global Recombinant Human CNTF Sales in Volume by Region: 2019-2024
5.2.2 Global Recombinant Human CNTF Sales in Volume Forecast by Region (2025-2030)
5.3 Global Recombinant Human CNTF Market Size in Value by Region (2019-2030)
5.3.1 Global Recombinant Human CNTF Sales in Value by Region: 2019-2024
5.3.2 Global Recombinant Human CNTF Sales in Value by Region: 2025-2030
6 Americas
6.1 Americas Recombinant Human CNTF Market Size YoY Growth 2019-2030
6.2 Americas Recombinant Human CNTF Sales in Volume, by Type (2019, 2023 & 2030)
6.3 Americas Recombinant Human CNTF Sales in Volume, by Application (2019, 2023 & 2030)
6.4 Americas Recombinant Human CNTF Market Facts & Figures by Country (2019, 2023 & 2030)
6.4.1 Americas Recombinant Human CNTF Sales in Value by Country (2019, 2023 & 2030)
6.4.2 Americas Recombinant Human CNTF Sales in Volume by Country (2019, 2023 & 2030)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Recombinant Human CNTF Market Size YoY Growth 2019-2030
7.2 EMEA Recombinant Human CNTF Sales in Volume, by Type (2019, 2023 & 2030)
7.3 EMEA Recombinant Human CNTF Sales in Volume, by Application (2019, 2023 & 2030)
7.4 EMEA Recombinant Human CNTF Market Facts & Figures by Country (2019, 2023 & 2030)
7.4.1 EMEA Recombinant Human CNTF Sales in Value by Country (2019, 2023 & 2030)
7.4.2 EMEA Recombinant Human CNTF Sales in Volume by Country (2019, 2023 & 2030)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Recombinant Human CNTF Market Size YoY Growth 2019-2030
8.2 China Recombinant Human CNTF Sales in Volume, by Type (2019, 2023 & 2030)
8.3 China Recombinant Human CNTF Sales in Volume, by Application (2019, 2023 & 2030)
9 APAC
9.1 APAC Recombinant Human CNTF Market Size YoY Growth 2019-2030
9.2 APAC Recombinant Human CNTF Sales in Volume, by Type (2019, 2023 & 2030)
9.3 APAC Recombinant Human CNTF Sales in Volume, by Application (2019, 2023 & 2030)
9.4 APAC Recombinant Human CNTF Market Facts & Figures by Country (2019, 2023 & 2030)
9.4.1 APAC Recombinant Human CNTF Sales in Value by Country (2019, 2023 & 2030)
9.4.2 APAC Recombinant Human CNTF Sales in Volume by Country (2019, 2023 & 2030)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 STEMCELL
10.1.1 STEMCELL Company Information
10.1.2 STEMCELL Description and Business Overview
10.1.3 STEMCELL Recombinant Human CNTF Sales, Revenue and Gross Margin (2019-2024)
10.1.4 STEMCELL Recombinant Human CNTF Products Offered
10.1.5 STEMCELL Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Description and Business Overview
10.2.3 Merck Recombinant Human CNTF Sales, Revenue and Gross Margin (2019-2024)
10.2.4 Merck Recombinant Human CNTF Products Offered
10.2.5 Merck Recent Development
10.3 YEASEN
10.3.1 YEASEN Company Information
10.3.2 YEASEN Description and Business Overview
10.3.3 YEASEN Recombinant Human CNTF Sales, Revenue and Gross Margin (2019-2024)
10.3.4 YEASEN Recombinant Human CNTF Products Offered
10.3.5 YEASEN Recent Development
10.4 BPS Bioscience
10.4.1 BPS Bioscience Company Information
10.4.2 BPS Bioscience Description and Business Overview
10.4.3 BPS Bioscience Recombinant Human CNTF Sales, Revenue and Gross Margin (2019-2024)
10.4.4 BPS Bioscience Recombinant Human CNTF Products Offered
10.4.5 BPS Bioscience Recent Development
10.5 R&D Systems, Inc.
10.5.1 R&D Systems, Inc. Company Information
10.5.2 R&D Systems, Inc. Description and Business Overview
10.5.3 R&D Systems, Inc. Recombinant Human CNTF Sales, Revenue and Gross Margin (2019-2024)
10.5.4 R&D Systems, Inc. Recombinant Human CNTF Products Offered
10.5.5 R&D Systems, Inc. Recent Development
10.6 Thermo Fisher Scientific Inc.
10.6.1 Thermo Fisher Scientific Inc. Company Information
10.6.2 Thermo Fisher Scientific Inc. Description and Business Overview
10.6.3 Thermo Fisher Scientific Inc. Recombinant Human CNTF Sales, Revenue and Gross Margin (2019-2024)
10.6.4 Thermo Fisher Scientific Inc. Recombinant Human CNTF Products Offered
10.6.5 Thermo Fisher Scientific Inc. Recent Development
10.7 Cell Guidance Systems LLC
10.7.1 Cell Guidance Systems LLC Company Information
10.7.2 Cell Guidance Systems LLC Description and Business Overview
10.7.3 Cell Guidance Systems LLC Recombinant Human CNTF Sales, Revenue and Gross Margin (2019-2024)
10.7.4 Cell Guidance Systems LLC Recombinant Human CNTF Products Offered
10.7.5 Cell Guidance Systems LLC Recent Development
10.8 Abcam Limited
10.8.1 Abcam Limited Company Information
10.8.2 Abcam Limited Description and Business Overview
10.8.3 Abcam Limited Recombinant Human CNTF Sales, Revenue and Gross Margin (2019-2024)
10.8.4 Abcam Limited Recombinant Human CNTF Products Offered
10.8.5 Abcam Limited Recent Development
10.9 ACROBiosystems
10.9.1 ACROBiosystems Company Information
10.9.2 ACROBiosystems Description and Business Overview
10.9.3 ACROBiosystems Recombinant Human CNTF Sales, Revenue and Gross Margin (2019-2024)
10.9.4 ACROBiosystems Recombinant Human CNTF Products Offered
10.9.5 ACROBiosystems Recent Development
10.10 Proteintech Group, Inc
10.10.1 Proteintech Group, Inc Company Information
10.10.2 Proteintech Group, Inc Description and Business Overview
10.10.3 Proteintech Group, Inc Recombinant Human CNTF Sales, Revenue and Gross Margin (2019-2024)
10.10.4 Proteintech Group, Inc Recombinant Human CNTF Products Offered
10.10.5 Proteintech Group, Inc Recent Development
10.11 BioLegend, Inc
10.11.1 BioLegend, Inc Company Information
10.11.2 BioLegend, Inc Description and Business Overview
10.11.3 BioLegend, Inc Recombinant Human CNTF Sales, Revenue and Gross Margin (2019-2024)
10.11.4 BioLegend, Inc Recombinant Human CNTF Products Offered
10.11.5 BioLegend, Inc Recent Development
10.12 InVitria
10.12.1 InVitria Company Information
10.12.2 InVitria Description and Business Overview
10.12.3 InVitria Recombinant Human CNTF Sales, Revenue and Gross Margin (2019-2024)
10.12.4 InVitria Recombinant Human CNTF Products Offered
10.12.5 InVitria Recent Development
10.13 Sinobiological
10.13.1 Sinobiological Company Information
10.13.2 Sinobiological Description and Business Overview
10.13.3 Sinobiological Recombinant Human CNTF Sales, Revenue and Gross Margin (2019-2024)
10.13.4 Sinobiological Recombinant Human CNTF Products Offered
10.13.5 Sinobiological Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Recombinant Human CNTF Industry Chain Analysis
11.2 Recombinant Human CNTF Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Recombinant Human CNTF Production Mode & Process
11.4 Recombinant Human CNTF Sales and Marketing
11.4.1 Recombinant Human CNTF Sales Channels
11.4.2 Recombinant Human CNTF Distributors
11.5 Recombinant Human CNTF Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Recombinant Human CNTF CAGR in Value, United States VS Global, 2019 VS 2023 VS 2030
Table 2. Recombinant Human CNTF Market Trends
Table 3. Recombinant Human CNTF Market Drivers
Table 4. Recombinant Human CNTF Market Challenges
Table 5. Recombinant Human CNTF Market Restraints
Table 6. Global Recombinant Human CNTF Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 7. United States Recombinant Human CNTF Sales Growth Rate (CAGR) by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global Recombinant Human CNTF Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 9. United States Recombinant Human CNTF Sales Growth Rate (CAGR) by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 10. Global Key Manufacturers of Recombinant Human CNTF, Ranked by Revenue (2023) & (US$ Million)
Table 11. Global Recombinant Human CNTF Revenue by Manufacturer, (US$ Million) & (2019-2024)
Table 12. Global Recombinant Human CNTF Revenue Share by Manufacturer, 2019-2024
Table 13. Global Recombinant Human CNTF Sales by Manufacturer, (K Units), 2019-2024
Table 14. Global Recombinant Human CNTF Sales Share by Manufacturer, 2019-2024
Table 15. Global Recombinant Human CNTF Price by Manufacturer (2019-2024) & (US$/Unit)
Table 16. Global Recombinant Human CNTF Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Recombinant Human CNTF by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human CNTF as of 2023)
Table 18. Global Key Manufacturers of Recombinant Human CNTF, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Recombinant Human CNTF, Product Offered and Application
Table 20. Global Key Manufacturers of Recombinant Human CNTF, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Recombinant Human CNTF in United States, Ranked by Revenue (2023) & (US$ million)
Table 23. United States Recombinant Human CNTF Revenue by Players, (US$ Million) & (2019-2024)
Table 24. United States Recombinant Human CNTF Revenue Share by Players, (2019-2024)
Table 25. United States Recombinant Human CNTF Sales by Players, (K Units) & (2019-2024)
Table 26. United States Recombinant Human CNTF Sales Share by Players, (2019-2024)
Table 27. Global Recombinant Human CNTF Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 28. Global Recombinant Human CNTF Sales in Volume by Region (2019-2024) & (K Units)
Table 29. Global Recombinant Human CNTF Sales in Volume Forecast by Region (2025-2030) & (K Units)
Table 30. Global Recombinant Human CNTF Sales in Value by Region (2019-2024) & (US$ Million)
Table 31. Global Recombinant Human CNTF Sales in Value Forecast by Region (2025-2030) & (US$ Million)
Table 32. Americas Recombinant Human CNTF Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. Americas Recombinant Human CNTF Sales in Value by Country (2019-2024) & (US$ Million)
Table 34. Americas Recombinant Human CNTF Sales in Value by Country (2025-2030) & (US$ Million)
Table 35. Americas Recombinant Human CNTF Sales in Volume by Country (2019-2024) & (K Units)
Table 36. Americas Recombinant Human CNTF Sales in Volume by Country (2025-2030) & (K Units)
Table 37. EMEA Recombinant Human CNTF Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. EMEA Recombinant Human CNTF Sales in Value by Country (2019-2024) & (US$ Million)
Table 39. EMEA Recombinant Human CNTF Sales in Value by Country (2025-2030) & (US$ Million)
Table 40. EMEA Recombinant Human CNTF Sales in Volume by Country (2019-2024) & (K Units)
Table 41. EMEA Recombinant Human CNTF Sales in Volume by Country (2025-2030) & (K Units)
Table 42. APAC Recombinant Human CNTF Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. APAC Recombinant Human CNTF Sales in Value by Country (2019-2024) & (US$ Million)
Table 44. APAC Recombinant Human CNTF Sales in Value by Country (2025-2030) & (US$ Million)
Table 45. APAC Recombinant Human CNTF Sales in Volume by Country (2019-2024) & (K Units)
Table 46. APAC Recombinant Human CNTF Sales in Volume by Country (2025-2030) & (K Units)
Table 47. STEMCELL Company Information
Table 48. STEMCELL Description and Business Overview
Table 49. STEMCELL Recombinant Human CNTF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 50. STEMCELL Recombinant Human CNTF Product
Table 51. STEMCELL Recent Development
Table 52. Merck Company Information
Table 53. Merck Description and Business Overview
Table 54. Merck Recombinant Human CNTF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 55. Merck Recombinant Human CNTF Product
Table 56. Merck Recent Development
Table 57. YEASEN Company Information
Table 58. YEASEN Description and Business Overview
Table 59. YEASEN Recombinant Human CNTF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. YEASEN Recombinant Human CNTF Product
Table 61. YEASEN Recent Development
Table 62. BPS Bioscience Company Information
Table 63. BPS Bioscience Description and Business Overview
Table 64. BPS Bioscience Recombinant Human CNTF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. BPS Bioscience Recombinant Human CNTF Product
Table 66. BPS Bioscience Recent Development
Table 67. R&D Systems, Inc. Company Information
Table 68. R&D Systems, Inc. Description and Business Overview
Table 69. R&D Systems, Inc. Recombinant Human CNTF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. R&D Systems, Inc. Recombinant Human CNTF Product
Table 71. R&D Systems, Inc. Recent Development
Table 72. Thermo Fisher Scientific Inc. Company Information
Table 73. Thermo Fisher Scientific Inc. Description and Business Overview
Table 74. Thermo Fisher Scientific Inc. Recombinant Human CNTF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Thermo Fisher Scientific Inc. Recombinant Human CNTF Product
Table 76. Thermo Fisher Scientific Inc. Recent Development
Table 77. Cell Guidance Systems LLC Company Information
Table 78. Cell Guidance Systems LLC Description and Business Overview
Table 79. Cell Guidance Systems LLC Recombinant Human CNTF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Cell Guidance Systems LLC Recombinant Human CNTF Product
Table 81. Cell Guidance Systems LLC Recent Development
Table 82. Abcam Limited Company Information
Table 83. Abcam Limited Description and Business Overview
Table 84. Abcam Limited Recombinant Human CNTF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Abcam Limited Recombinant Human CNTF Product
Table 86. Abcam Limited Recent Development
Table 87. ACROBiosystems Company Information
Table 88. ACROBiosystems Description and Business Overview
Table 89. ACROBiosystems Recombinant Human CNTF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. ACROBiosystems Recombinant Human CNTF Product
Table 91. ACROBiosystems Recent Development
Table 92. Proteintech Group, Inc Company Information
Table 93. Proteintech Group, Inc Description and Business Overview
Table 94. Proteintech Group, Inc Recombinant Human CNTF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Proteintech Group, Inc Recombinant Human CNTF Product
Table 96. Proteintech Group, Inc Recent Development
Table 97. BioLegend, Inc Company Information
Table 98. BioLegend, Inc Description and Business Overview
Table 99. BioLegend, Inc Recombinant Human CNTF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. BioLegend, Inc Recombinant Human CNTF Product
Table 101. BioLegend, Inc Recent Development
Table 102. InVitria Company Information
Table 103. InVitria Description and Business Overview
Table 104. InVitria Recombinant Human CNTF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. InVitria Recombinant Human CNTF Product
Table 106. InVitria Recent Development
Table 107. Sinobiological Company Information
Table 108. Sinobiological Description and Business Overview
Table 109. Sinobiological Recombinant Human CNTF Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Sinobiological Recombinant Human CNTF Product
Table 111. Sinobiological Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. Recombinant Human CNTF Distributors List
Table 115. Recombinant Human CNTF Customers List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Human CNTF Product Picture
Figure 2. Global Recombinant Human CNTF Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Recombinant Human CNTF Market Size 2019-2030 (US$ Million)
Figure 4. Global Recombinant Human CNTF Sales 2019-2030 (K Units)
Figure 5. United States Recombinant Human CNTF Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 6. United States Recombinant Human CNTF Market Size 2019-2030 (US$ Million)
Figure 7. United States Recombinant Human CNTF Sales 2019-2030 (K Units)
Figure 8. United States Recombinant Human CNTF Market Share in Global, in Value (US$ Million) 2019-2030
Figure 9. United States Recombinant Human CNTF Market Share in Global, in Volume (K Units) 2019-2030
Figure 10. Recombinant Human CNTF Report Years Considered
Figure 11. Product Picture of Purity < 97%
Figure 12. Product Picture of Purity ≥ 97%
Figure 13. Global Recombinant Human CNTF Market Share by Type in 2023 & 2030
Figure 14. Global Recombinant Human CNTF Sales in Value by Type (2019-2030) & (US$ Million)
Figure 15. Global Recombinant Human CNTF Sales Market Share in Value by Type (2019-2030)
Figure 16. Global Recombinant Human CNTF Sales by Type (2019-2030) & (K Units)
Figure 17. Global Recombinant Human CNTF Sales Market Share in Volume by Type (2019-2030)
Figure 18. Global Recombinant Human CNTF Price by Type (2019-2030) & (US$/Unit)
Figure 19. United States Recombinant Human CNTF Market Share by Type in 2023 & 2030
Figure 20. United States Recombinant Human CNTF Sales in Value by Type (2019-2030) & (US$ Million)
Figure 21. United States Recombinant Human CNTF Sales Market Share in Value by Type (2019-2030)
Figure 22. United States Recombinant Human CNTF Sales by Type (2019-2030) & (K Units)
Figure 23. United States Recombinant Human CNTF Sales Market Share in Volume by Type (2019-2030)
Figure 24. United States Recombinant Human CNTF Price by Type (2019-2030) & (US$/Unit)
Figure 25. Product Picture of Laboratory
Figure 26. Product Picture of University
Figure 27. Product Picture of Others
Figure 28. Global Recombinant Human CNTF Market Share by Application in 2023 & 2030
Figure 29. Global Recombinant Human CNTF Sales in Value by Application (2019-2030) & (US$ Million)
Figure 30. Global Recombinant Human CNTF Sales Market Share in Value by Application (2019-2030)
Figure 31. Global Recombinant Human CNTF Sales by Application (2019-2030) & (K Units)
Figure 32. Global Recombinant Human CNTF Sales Market Share in Volume by Application (2019-2030)
Figure 33. Global Recombinant Human CNTF Price by Application (2019-2030) & (US$/Unit)
Figure 34. United States Recombinant Human CNTF Market Share by Application in 2023 & 2030
Figure 35. United States Recombinant Human CNTF Sales in Value by Application (2019-2030) & (US$ Million)
Figure 36. United States Recombinant Human CNTF Sales Market Share in Value by Application (2019-2030)
Figure 37. United States Recombinant Human CNTF Sales by Application (2019-2030) & (K Units)
Figure 38. United States Recombinant Human CNTF Sales Market Share in Volume by Application (2019-2030)
Figure 39. United States Recombinant Human CNTF Price by Application (2019-2030) & (US$/Unit)
Figure 40. The Top 5 and 10 Largest Manufacturers of Recombinant Human CNTF in the World: Market Share by Recombinant Human CNTF Revenue in 2023
Figure 41. Global Recombinant Human CNTF Market Size Market Share by Region: 2019 VS 2023 VS 2030
Figure 42. Global Recombinant Human CNTF Sales in Volume Market Share by Region (2019-2030)
Figure 43. Global Recombinant Human CNTF Sales in Value Market Share by Region (2019-2030)
Figure 44. Americas Recombinant Human CNTF Sales in Volume Growth Rate 2019-2030 (K Units)
Figure 45. Americas Recombinant Human CNTF Sales in Value Growth Rate 2019-2030 (US$ Million)
Figure 46. Americas Recombinant Human CNTF Sales by Type (2019-2030) & (K Units)
Figure 47. Americas Recombinant Human CNTF Sales Market Share in Volume by Type (2019-2030)
Figure 48. Americas Recombinant Human CNTF Sales by Application (2019-2030) & (K Units)
Figure 49. Americas Recombinant Human CNTF Sales Market Share in Volume by Application (2019-2030)
Figure 50. United States Recombinant Human CNTF Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 51. Canada Recombinant Human CNTF Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 52. Mexico Recombinant Human CNTF Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 53. Brazil Recombinant Human CNTF Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 54. EMEA Recombinant Human CNTF Sales in Volume Growth Rate 2019-2030 (K Units)
Figure 55. EMEA Recombinant Human CNTF Sales in Value Growth Rate 2019-2030 (US$ Million)
Figure 56. EMEA Recombinant Human CNTF Sales by Type (2019-2030) & (K Units)
Figure 57. EMEA Recombinant Human CNTF Sales Market Share in Volume by Type (2019-2030)
Figure 58. EMEA Recombinant Human CNTF Sales by Application (2019-2030) & (K Units)
Figure 59. EMEA Recombinant Human CNTF Sales Market Share in Volume by Application (2019-2030)
Figure 60. Europe Recombinant Human CNTF Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 61. Middle East Recombinant Human CNTF Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 62. Africa Recombinant Human CNTF Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 63. China Recombinant Human CNTF Sales in Volume Growth Rate 2019-2030 (K Units)
Figure 64. China Recombinant Human CNTF Sales in Value Growth Rate 2019-2030 (US$ Million)
Figure 65. China Recombinant Human CNTF Sales by Type (2019-2030) & (K Units)
Figure 66. China Recombinant Human CNTF Sales Market Share in Volume by Type (2019-2030)
Figure 67. China Recombinant Human CNTF Sales by Application (2019-2030) & (K Units)
Figure 68. China Recombinant Human CNTF Sales Market Share in Volume by Application (2019-2030)
Figure 69. APAC Recombinant Human CNTF Sales in Volume Growth Rate 2019-2030 (K Units)
Figure 70. APAC Recombinant Human CNTF Sales in Value Growth Rate 2019-2030 (US$ Million)
Figure 71. APAC Recombinant Human CNTF Sales by Type (2019-2030) & (K Units)
Figure 72. APAC Recombinant Human CNTF Sales Market Share in Volume by Type (2019-2030)
Figure 73. APAC Recombinant Human CNTF Sales by Application (2019-2030) & (K Units)
Figure 74. APAC Recombinant Human CNTF Sales Market Share in Volume by Application (2019-2030)
Figure 75. Japan Recombinant Human CNTF Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 76. South Korea Recombinant Human CNTF Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 77. China Taiwan Recombinant Human CNTF Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 78. Southeast Asia Recombinant Human CNTF Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 79. India Recombinant Human CNTF Sales in Value Growth Rate (2019-2030) & (US$ Million)
Figure 80. Recombinant Human CNTF Value Chain
Figure 81. Recombinant Human CNTF Production Process
Figure 82. Channels of Distribution (Direct Vs Distribution)
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 7% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What was the global market size of Recombinant Human CNTF in 2030?
What is the annual compound growth rate of the global Recombinant Human CNTF market size from 2024 to 2030?
What was the global market size of Recombinant Human CNTF in 2024?
Which companies rank high in the global Recombinant Human CNTF market?
Related Reports
Global Recombinant Human CNTF Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Recombinant Human CNTF market is projected to grow from US$ 224 million in 2025 to US$ 358 million by 2032, at a CAGR of 7.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 170
USD 4900.00
(Single User License)
Global Recombinant Human CNTF Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Recombinant Human CNTF market size was US$ 224 million in 2025 and is forecast to reach a readjusted size of US$ 358 million by 2032 with a CAGR of 7.0% during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 96
USD 4250.00
(Single User License)
Recombinant Human CNTF- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Recombinant Human CNTF was estimated to be worth US$ 224 million in 2025 and is projected to reach US$ 358 million, growing at a CAGR of 7.0% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 128
USD 3950.00
(Single User License)
Global Recombinant Human CNTF Market Research Report 2026
The global Recombinant Human CNTF market was valued at US$ 224 million in 2025 and is anticipated to reach US$ 358 million by 2032, at a CAGR of 7.0% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 127
USD 2900.00
(Single User License)
Global Recombinant Human CNTF Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Recombinant Human CNTF market is projected to grow from US$ 211 million in 2024 to US$ 337 million by 2031, at a CAGR of 7.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 169
USD 4900.00
(Single User License)
Global Recombinant Human CNTF Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Recombinant Human CNTF market size was US$ 211 million in 2024 and is forecast to a readjusted size of US$ 337 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 100
USD 4250.00
(Single User License)
Recombinant Human CNTF - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Recombinant Human CNTF was estimated to be worth US$ 211 million in 2024 and is forecast to a readjusted size of US$ 337 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 115
USD 3950.00
(Single User License)
Global Recombinant Human CNTF Market Research Report 2025
The global market for Recombinant Human CNTF was valued at US$ 211 million in the year 2024 and is projected to reach a revised size of US$ 337 million by 2031, growing at a CAGR of 7.0% during the forecast period.
Published Date: 2025-03-10
Pages: 93
USD 2900.00
(Single User License)
Global Recombinant Human CNTF Market Insights, Forecast to 2030
The global Recombinant Human CNTF market is projected to grow from US$ 211 million in 2024 to US$ 317 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.0% during the forecast period.
Published Date: 2024-11-12
Pages: 146
USD 4900.00
(Single User License)
Recombinant Human CNTF- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Recombinant Human CNTF was estimated to be worth US$ 198 million in 2023 and is forecast to a readjusted size of US$ 317 million by 2030 with a CAGR of 7.0% during the forecast period 2024-2030.
Published Date: 2024-11-12
Pages: 130
USD 3950.00
(Single User License)
Global Recombinant Human CNTF Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Recombinant Human CNTF market is projected to grow from US$ 224 million in 2025 to US$ 358 million by 2032, at a CAGR of 7.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 170
USD 4900.00 (Single User License)Global Recombinant Human CNTF Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Recombinant Human CNTF market size was US$ 224 million in 2025 and is forecast to reach a readjusted size of US$ 358 million by 2032 with a CAGR of 7.0% during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 96
USD 4250.00 (Single User License)Recombinant Human CNTF- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Recombinant Human CNTF was estimated to be worth US$ 224 million in 2025 and is projected to reach US$ 358 million, growing at a CAGR of 7.0% from 2026 to 2032.
Published: 2026-01-08
Pages: 128
USD 3950.00 (Single User License)Global Recombinant Human CNTF Market Research Report 2026
The global Recombinant Human CNTF market was valued at US$ 224 million in 2025 and is anticipated to reach US$ 358 million by 2032, at a CAGR of 7.0% from 2026 to 2032.
Published: 2026-01-08
Pages: 127
USD 2900.00 (Single User License)Global Recombinant Human CNTF Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Recombinant Human CNTF market is projected to grow from US$ 211 million in 2024 to US$ 337 million by 2031, at a CAGR of 7.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 169
USD 4900.00 (Single User License)Global Recombinant Human CNTF Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Recombinant Human CNTF market size was US$ 211 million in 2024 and is forecast to a readjusted size of US$ 337 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 100
USD 4250.00 (Single User License)Recombinant Human CNTF - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Recombinant Human CNTF was estimated to be worth US$ 211 million in 2024 and is forecast to a readjusted size of US$ 337 million by 2031 with a CAGR of 7.0% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 115
USD 3950.00 (Single User License)Global Recombinant Human CNTF Market Research Report 2025
The global market for Recombinant Human CNTF was valued at US$ 211 million in the year 2024 and is projected to reach a revised size of US$ 337 million by 2031, growing at a CAGR of 7.0% during the forecast period.
Published: 2025-03-10
Pages: 93
USD 2900.00 (Single User License)Global Recombinant Human CNTF Market Insights, Forecast to 2030
The global Recombinant Human CNTF market is projected to grow from US$ 211 million in 2024 to US$ 317 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.0% during the forecast period.
Published: 2024-11-12
Pages: 146
USD 4900.00 (Single User License)Recombinant Human CNTF- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Recombinant Human CNTF was estimated to be worth US$ 198 million in 2023 and is forecast to a readjusted size of US$ 317 million by 2030 with a CAGR of 7.0% during the forecast period 2024-2030.
Published: 2024-11-12
Pages: 130
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4350.00
USD 6525.00
USD 8700.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now